Delirium, Dementia, Amnestic, Cognitive Disorders  >>  bryostatin 1 (NSC 339555)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bryostatin 1 (NSC 339555) / Synaptogenix
NCT02221947: Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease

Terminated
1/2
9
US
Bryostatin 1, Placebo
Neurotrope Bioscience, Inc., Blanchette Rockefeller Neurosciences Insitute
Alzheimer's Disease
12/14
12/14

Download Options